The occurrence of deoxyribonucleic acid (DNA) antibodies in the sera of patients with systemic lupus erythematosus (SLE) has been established by several authors by different techniques. Their diagnostic value has been studied in more extensive series of patients by Jokinen and Makitalo (1960: passive haemagglutination and complement-fixation), Kayhoe, Nasou, and Bozicevich (1960: bentonite flocculation), Rothfield, Phythyon, McEwen and Miescher (1961: conglutinin-complement-fixation), and Seligmann (1963: precipitation, complementfixation, and bentonite flocculation). Lawlis (1958) described a passive haemagglutination method using formalinized erythrocytes sensitized with DNA. This method was used in diagnosis by Oliveira Lima, Fraga and Seabra (1961) and Lachmann (1964) . Using the same method it is the aim of the present paper to throw light on the clinical significance of the occurrence of DNA antibodies within an extensive and diversified series of hospital patients.
Material
The series comprises 1,080 patients from the Second Medical Clinic, Helsinki University Central Hospital, where patients from all over Finland report for treatment, and the Medical Department, Maria Hospital, which receives patients domiciled in Helsinki. Independently of the authors, the physicians in charge of the patients had DNA antibody tests made for differential diagnosis. SLE was diagnosed in 63 of the patients by the physician in charge of the case at the time, and the patients were also seen by the authors. Nearly all these patients had been hospitalized more than once, and most of them had been followed clinically for several years. The diagnosis of SLE was based primarily on the clinical picture, L.E.-cell test, and positive biopsy. The most significant clinical and laboratory findings are given in Table I (overleaf), and the distribution of patients by disease activity and by corticosteroid treatment in Table II  (overleaf). Those patients were regarded as untreated who had received no corticosteroids for at least one month before the DNA haemagglutination test. The 1,017 patients other than those with SLE are shown in Table IV (overleaf), which gives the diagnosis regarded as most important in each case.
Method
The passive haemagglutination method using DNA coupled to formalinized erythrocytes (Lawlis, 1958) Coupling Technique.-Formalinized erythrocytes were washed five times in phosphate-saline. A 10 per cent. suspension of erythrocytes was made in the coupling solution containing DNA 0 1 mg./ml. This was allowed to dissolve overnight before coupling in a 370 C. water bath. This mixture was incubated in the water bath with mixing every 30 min. for 4 hrs. Erythrocytes were then washed three times with phosphate-saline and made up to a 1 per cent. suspension in phosphate-saline.
Agglutination Test.
-The sera to be tested were diluted 1: 4, 1:8, etc., inphosphate-salinecontaining 1: lOOnormal rabbit serum in test tubes of 10 mm. diameter. Each tube contained 0 5 ml. serum dilution, to which 0 1 ml. cell suspension was added. Formalinized but uncoupled cells were used as controls. The result was read after 4 to 5 hrs and the end-point was taken as the highest serum dilution giving an even coating of cells over the bottom of the tube. Sera giving agglutination were re-tested after absorption with formalinized erythrocytes. A positive control serum with known titre was included in each series. The sera giving agglutination in a dilution of 1:8 or more were regarded as positive.
Results
The chief results are shown in Tables I, It, III, and IV. DNA antibodies were detected in nineteen (31 per cent.) of the 63 SLE patients. The highest positive titre in the series was 1: 512. In addition to the findings presented in Table I , one patient with DNA antibodies had haemolytic anaemia and two showed biologically false positive tests for syphilis. Among the 44 patients without DNA antibodies two had malabsorption and three gave biologically false positive tests for syphilis. Table II shows the clear correlation between the occurrence of DNA antibodies and disease activity.
All but one of the positive cases had active SLE. Contrariwise in 33 of the 44 negative cases, the disease was in remission. A few patients with antibodies were followed up for over 6 months, and the antibodies disappeared or decreased in titre when the disease activity diminished whether spontaneously or after cortico-steroid treatment. Recrudescence of the disease was attended by reappearance of the antibodies.
In order to discover the primary symptomatic differences, if any, between the nineteen SLE patients with DNA antibodies and those without, the positive cases were compared with the 25 negative cases which had not been treated with corticosteroids (Table III) . In patients with DNA antibodies the disease seems to have begun at a much earlier age and to have caused a greater number of organic manifestations. Rothfield and others (1961) . The present results suggest that the occurrence of DNA antibodies in SLE is not particularly frequent, in that only nineteen out of 63 patients gave a positive reaction. The proportion might well have been higher had the negative group been examined repeatedly over a longer period. Moreover, nearly half the patients in the series had been treated with corticosteroids, which evidently reduced the number of positive cases.
As regards both specificity and sensitivity, the results given by passive haemagglutination with tanned erythrocytes differ from those obtained with other techniques (Jokinen and Miikitalo, 1960) .
It is quite possible, however, that this technique, described by Miescher and Striissle (1957) , is based on the use of a DNA-containing protein as antigen. This is suggested by its adhesion to tannin and the high N/P ratio . The present authors have not obtained positive results with this technique and SLE sera using pure and highly polymerized DNA preparations as antigens.
Our present results show that the occurrence of DNA antibodies depends on disease activity, as was also shown by other techniques (Kayhoe and others, 1960; Seligmann, 1963) . It is also possible that SLE with DNA antibodies may differ from SLE without DNA antibodies, as suggested by the earlier onset, the greater number of symptoms, and the more severe clinical course.
The DNA haemagglutination test appears to be useful in the differential diagnosis of SLE. The results are readily reproducible and highly specific. Rheumatoid arthritis has been found to be attended by antibodies to nucleoprotein, histone, and whole nucleus (Rothfield and others, 1961; Dorner, Enderlin, Spiegelberg, and Miescher, 1961; Thompson, 1962, Ward, Johnson, and Holborow, 1964) ; antibodies to nucleoprotein have been found in systemic scleroderma and dermatomyositis (Friou, 1958; Bardawil, Toy, Galins, and Bayles, 1958; Scalettar, Marcus, Simonton, and Muschel, 1960) . Positive cell tests have been reported in all these diseases (Kievits, Goslings, Schuit, and Hijmans, 1956; Marmont, 1959; Rothfield and others, 1961 Reacci6n de hemaglutinaci6n del ADN en el diagn6stico del lupus eritematoso diseminado SUMARIO Sirviendose del metodo de aglutinacion pasiva de eritrocitos formalinizados y sensibilizados con el ADN, se estudiaron los sueros de 1.080 enfermos hospitalizados, 63 de los cuales sufrieron de lupus eritematoso diseminado. En 19 de estos anticuerpos contra el ADN fueron encontrados en uno de los periodos de la enfermedad, pero en los demas 44 enfermos su ausencia fue total. En 231 pacientes con otras "enfermedades del colageno" y en los 786 con varias enfermedades el anticuerpo anti-ADN no fue encontrado.
La ocurrencia de los anticuerpos anti-ADN fue inequivocadamente ligada a la actividad morbosa. Estos anticuerpos fueron hallados en 18 de los 30 casos activos, pero s6lo en uno de los 37 casos en remision, tanto espontanea como c6rtico-terapeutica. Ademas, los enfermos que tuvieron el anticuerpo anti-ADN parecieron caracterizarse tambien por un comienzo mas temprano y por sintomas mAs abundantes. 
